Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Preterm Labor, Premature Birth Clear all

Conditions: Infant Mortality, Preterm Birth, Low Birth Weight, Neonatal Mortality, Perinatal Mortality
Interventions: Iron (27 mg) - folic acid (600 ug), Multiple micronutrient; Dietary Supplement
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 12 Years to 45 Years · Female only
Enrollment: 44,567 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Prematurity, Symptomatic Respiratory Disease, Bronchopulmonary Dysplasia
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: Up to 7 Days
Enrollment: 277 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Buffalo, New York • Rochester, New York

Conditions: Autism, Prematurity
Interventions: Eye-tracking device; Device
Lead sponsor: Indiana University; Other
Eligibility: 14 Months to 48 Months
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Infantile Hemangioma, Very Low Birth Weight Infants
Interventions: topical 0.5% Timolol maleate, Control (placebo) group; Drug
Lead sponsor: Alice K. Gong; Other
Eligibility: Up to 6 Months
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
Interventions: Standard Cord Clamping, Delayed Cord Clamping; Procedure
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 0 Minutes to 1 Minute
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000
U.S. locations: 4
States / cities: Birmingham, Alabama • Cincinnati, Ohio • Cleveland, Ohio + 1 more

Conditions: Preterm Delivery
Interventions: Not listed
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 5
States / cities: San Jose, California • New Haven, Connecticut • Atlanta, Georgia + 2 more

Conditions: Retinopathy of Prematurity
Interventions: Bevacizumab, Conventional Laser for ROP; Drug · Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 4 Weeks to 22 Weeks
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 15
States / cities: Pasadena, California • Denver, Colorado • Peoria, Illinois + 7 more

Conditions: Respiratory Compliance, Functional Residual Capacity, Pulmonary Function Testing
Interventions: betamethasone, placebo; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 15 Years and older · Female only
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2009
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Preterm Birth, Breast Milk Expression, Nutrition Disorder, Infant, Brain Development Abnormality, Neurodevelopmental Disorders
Interventions: Individually targeted fortification; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 1 Day to 21 Days
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Premature Birth, Sepsis
Interventions: Not listed
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: Up to 3 Days
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Prematurity, Light-For-Dates, Enteral Feeding Intolerance
Interventions: Early HMF, Delayed HMF; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 4 Days
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Nosocomial Infections, Sepsis, Staphylococcal Infections, Candidemia
Interventions: Veronate; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 3 Days to 5 Days
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 85
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 71 more

Conditions: Preterm Birth
Interventions: Music Intervention (MI), Sham Control (SC); Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: New York, New York

Conditions: Adverse Pregnancy Outcome
Interventions: Lovenox 40mg; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Preterm Birth
Interventions: 17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement, 17 alpha-hydroxy progesterone caproate and Placebo supplement; Drug
Lead sponsor: The George Washington University Biostatistics Center; Other
Eligibility: Female only
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 12
States / cities: Birmingham, Alabama • Chicago, Illinois • Detroit, Michigan + 9 more

Conditions: Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus
Interventions: Survanta (beractant), Curosurf (poractant); Drug
Lead sponsor: Alan Fujii; Other
Eligibility: Up to 8 Hours
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Preterm Birth, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Up to 7 Days
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Jackson, Tennessee • Nashville, Tennessee

Conditions: Pregnancy, Premature Birth, Prenatal Care, Preterm Delivery, Preterm Birth
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 20,964 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Pregnancy
Interventions: Not listed
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 48 Hours
Enrollment: 1,090 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1994 – 1996
U.S. locations: 11
States / cities: Palo Alto, California • New Haven, Connecticut • Washington D.C., District of Columbia + 8 more

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Hypotension, Blood Pressure
Interventions: Dopamine, Hydrocortisone, Infusion Placebo, Syringe Placebo; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 24 Hours
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 13 more

Conditions: Hyper Bilirubinemia, Premature Infant
Interventions: Phototherapy lights; Device
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 22 Weeks to 27 Weeks
Enrollment: 1,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 19
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 15 more

Conditions: Preterm Birth
Interventions: 17-Hydroxyprogesterone Caproate 250 mg IM Dose, 17-Hydroxyprogesterone Caproate 275 mg SC Dose; Drug
Lead sponsor: Steve N. Caritis, MD; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 4
States / cities: Newark, Delaware • Durham, North Carolina • Winston-Salem, North Carolina + 1 more

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia (BPD)
Interventions: Not listed
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 36 Weeks to 37 Weeks
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 21
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 17 more

Conditions: Preterm Birth, Pregnancy, Multifetal
Interventions: 17 alpha-hydroxyprogesterone caproate (17P); Drug
Lead sponsor: The George Washington University Biostatistics Center; Other
Eligibility: Female only
Enrollment: 795 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 14
States / cities: Birmingham, Alabama • Chicago, Illinois • Detroit, Michigan + 11 more

Search by objective public record fields.

Antenatal Micronutrient Supplementation and Infant Survival

Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies

Eye Tracking and Autism in Former Preterm Infants

Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)

Delayed Cord Clamping in VLBW Infants

Comparison of Fetal Fibronectin (fFN) Specimen Collection Methodologies: With Speculum Versus Without Speculum

Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity

Rescue Antenatal Steroids and Pulmonary Function Tests in Preterm Infants

Targeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development

Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation

Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants

Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants

Music Intervention for Preterm Birth

Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project

Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies

Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants

Improving Prematurity-Related Respiratory Outcomes at Vanderbilt

Use of the Perinatal Database and Biologic Tissue Bank at The Perinatology Research Branch (PRB)

Development of Standards for the New Ballard Maturation Score

Early Blood Pressure Management in Extremely Premature Infants

Cycled Phototherapy

17-OHPC in Pregnancy: IM vs SC Routes

Physiologic Definition of Bronchopulmonary Dysplasia

Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)